Future studies will build upon our exciting findings that SLE-associated mediators IL-6 and IP-10 are associated with genetic variants of IFIH1 that directly impact MDA5-mediated secretion of these soluble mediators in SLE patients and their blood relatives. This evidence concerns the gene IL6 and systemic lupus erythematosus.